ROBERT LANGER Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROBERT LANGER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT LANGER. ROBERT LANGER is Director in Ocata Therapeutics, Inc. ($ACTC) and Director in Lyra Therapeutics, Inc. ($LYRA) and Director in BIND Therapeutics, Inc ($BIND) and Director in Kala Pharmaceuticals, Inc. ($KALA) and Director in Moderna, Inc. ($MRNA) and Director in Frequency Therapeutics, Inc. ($FREQ) and Director in Rubius Therapeutics, Inc. ($RUBY) and Director in Seer, Inc. ($SEER).
Latest Insider Trading Transactions of ROBERT LANGER
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BIND, FREQ, KALA, LYRA, MRNA, ACTC, RUBY, SEER
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 30 2021 | MRNA | Moderna, Inc. | LANGER ROBERT | Director | Option Exercise | A | 0.00 | 703 | 0 | 703 | |
Apr 30 2021 | MRNA | Moderna, Inc. | LANGER ROBERT | Director | Option Exercise | A | 178.68 | 4,081 | 729,193 | 4,081 | |
Dec 11 2020 | SEER | Seer, Inc. | LANGER ROBERT | Director | Option Exercise | A | 19.00 | 18,691 | 355,129 | 18,691 | |
Nov 19 2020 | FREQ | Frequency Therapeu ... | LANGER ROBERT | Director | Gift | G | 0.00 | 56,912 | 0 | 214,326 | 271.2 K to 214.3 K (-20.98 %) |
Jun 12 2020 | FREQ | Frequency Therapeu ... | LANGER ROBERT | Director | Option Exercise | A | 18.63 | 14,846 | 276,581 | 14,846 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | LANGER ROBERT | Director | Option Exercise | C | 0.00 | 23,057 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | LANGER ROBERT | Director | Buy | C | 0.00 | 668 | 0 | 15,167 | 14.5 K to 15.2 K (+4.61 %) |
May 01 2020 | LYRA | Lyra Therapeutics, ... | LANGER ROBERT | Director | Option Exercise | A | 16.00 | 14,500 | 232,000 | 14,500 | |
Apr 30 2020 | MRNA | Moderna, Inc. | LANGER ROBERT | Director | Option Exercise | A | 46.37 | 18,270 | 847,180 | 18,270 | |
Oct 17 2019 | RUBY | Rubius Therapeutic ... | LANGER ROBERT | Director | Option Exercise | M | 0.15 | 7,500 | 1,125 | 120,000 | |
Oct 17 2019 | RUBY | Rubius Therapeutic ... | LANGER ROBERT | Director | Sell | S | 8.52 | 7,500 | 63,875 | 0 | 7.5 K to 0 (-100.00 %) |
Oct 17 2019 | RUBY | Rubius Therapeutic ... | LANGER ROBERT | Director | Buy | M | 0.15 | 7,500 | 1,125 | 7,500 | 0 to 7.5 K |
Jul 17 2019 | RUBY | Rubius Therapeutic ... | LANGER ROBERT | Director | Option Exercise | M | 0.15 | 7,500 | 1,125 | 127,500 | |
Jul 17 2019 | RUBY | Rubius Therapeutic ... | LANGER ROBERT | Director | Sell | S | 14.94 | 7,500 | 112,049 | 0 | 7.5 K to 0 (-100.00 %) |
Jul 17 2019 | RUBY | Rubius Therapeutic ... | LANGER ROBERT | Director | Buy | M | 0.15 | 7,500 | 1,125 | 7,500 | 0 to 7.5 K |
Jun 28 2019 | MRNA | Moderna, Inc. | LANGER ROBERT | Director | Option Exercise | A | 14.34 | 54,660 | 783,824 | 54,660 | |
May 28 2019 | RUBY | Rubius Therapeutic ... | LANGER ROBERT | Director | Option Exercise | A | 16.27 | 25,000 | 406,750 | 25,000 | |
Apr 17 2019 | RUBY | Rubius Therapeutic ... | LANGER ROBERT | Director | Option Exercise | M | 0.15 | 7,500 | 1,125 | 135,000 | |
Apr 17 2019 | RUBY | Rubius Therapeutic ... | LANGER ROBERT | Director | Sell | S | 17.57 | 7,500 | 131,799 | 0 | 7.5 K to 0 (-100.00 %) |
Apr 17 2019 | RUBY | Rubius Therapeutic ... | LANGER ROBERT | Director | Buy | M | 0.15 | 7,500 | 1,125 | 7,500 | 0 to 7.5 K |
Jan 18 2019 | RUBY | Rubius Therapeutic ... | LANGER ROBERT | Director | Option Exercise | M | 0.15 | 7,500 | 1,125 | 142,500 | |
Jan 18 2019 | RUBY | Rubius Therapeutic ... | LANGER ROBERT | Director | Sell | S | 14.59 | 7,500 | 109,444 | 0 | 7.5 K to 0 (-100.00 %) |
Jan 18 2019 | RUBY | Rubius Therapeutic ... | LANGER ROBERT | Director | Buy | M | 0.15 | 7,500 | 1,125 | 7,500 | 0 to 7.5 K |
Dec 13 2018 | MRNA | Moderna, Inc. | LANGER ROBERT | Director | Option Exercise | C | 0.00 | 4,559 | 0 | 0 | |
Dec 13 2018 | MRNA | Moderna, Inc. | LANGER ROBERT | Director | Buy | C | 0.00 | 4,559 | 0 | 11,466,961 | 11.5 M to 11.5 M (+0.04 %) |
Jul 18 2018 | RUBY | Rubius Therapeutic ... | LANGER ROBERT | Director | Option Exercise | A | 23.00 | 25,000 | 575,000 | 25,000 | |
Jun 15 2018 | KALA | Kala Pharmaceutica ... | LANGER ROBERT | Director | Option Exercise | A | 13.73 | 12,960 | 177,941 | 12,960 | |
Jul 21 2017 | KALA | Kala Pharmaceutica ... | LANGER ROBERT | Director | Option Exercise | A | 15.00 | 12,960 | 194,400 | 12,960 | |
Aug 30 2016 | BIND | DNIB UNWIND, INC. | LANGER ROBERT | Director | Option Exercise | M | 0.44 | 15,000 | 6,600 | 0 | |
Aug 30 2016 | BIND | DNIB UNWIND, INC. | LANGER ROBERT | Director | Buy | M | 0.44 | 15,000 | 6,600 | 738,424 | 723.4 K to 738.4 K (+2.07 %) |
Jun 22 2016 | BIND | BIND Therapeutics, ... | LANGER ROBERT | Director | Option Exercise | A | 0.44 | 15,000 | 6,600 | 15,000 | |
Feb 11 2016 | ACTC | Ocata Therapeutics ... | LANGER ROBERT | Director | Option Exercise | D | 8.36 | 5,000 | 41,800 | 0 | |
Feb 11 2016 | ACTC | Ocata Therapeutics ... | LANGER ROBERT | Director | Option Exercise | D | 6.39 | 5,000 | 31,950 | 0 | |
Feb 11 2016 | ACTC | Ocata Therapeutics ... | LANGER ROBERT | Director | Option Exercise | D | 6.17 | 5,000 | 30,850 | 0 | |
Feb 11 2016 | ACTC | Ocata Therapeutics ... | LANGER ROBERT | Director | Option Exercise | D | 5.79 | 5,000 | 28,950 | 0 | |
Feb 11 2016 | ACTC | Ocata Therapeutics ... | LANGER ROBERT | Director | Option Exercise | D | 9.00 | 5,000 | 45,000 | 0 | |
Feb 11 2016 | ACTC | Ocata Therapeutics ... | LANGER ROBERT | Director | Option Exercise | D | 20.00 | 20,000 | 400,000 | 0 | |
Feb 11 2016 | ACTC | Ocata Therapeutics ... | LANGER ROBERT | Director | Option Exercise | D | 14.30 | 1,250 | 17,875 | 0 | |
Feb 11 2016 | ACTC | Ocata Therapeutics ... | LANGER ROBERT | Director | Sell | U | 8.50 | 51,000 | 433,500 | 0 | 51 K to 0 (-100.00 %) |
Jan 04 2016 | ACTC | Ocata Therapeutics ... | LANGER ROBERT | Director | Option Exercise | A | 8.36 | 5,000 | 41,800 | 5,000 | |
Jan 04 2016 | ACTC | Ocata Therapeutics ... | LANGER ROBERT | Director | Grant | A | 0.00 | 1,250 | 0 | 52,250 | 51 K to 52.3 K (+2.45 %) |
Oct 01 2015 | ACTC | Ocata Therapeutics ... | LANGER ROBERT | Director | Grant | A | 0.00 | 1,250 | 0 | 51,000 | 49.8 K to 51 K (+2.51 %) |
Jul 02 2015 | ACTC | Ocata Therapeutics ... | LANGER ROBERT | Director | Grant | A | 0.00 | 1,250 | 0 | 49,750 | 48.5 K to 49.8 K (+2.58 %) |
Jun 10 2015 | BIND | BIND Therapeutics, ... | LANGER ROBERT | Director | Option Exercise | A | 5.87 | 15,000 | 88,050 | 15,000 | |
Apr 01 2015 | ACTC | Ocata Therapeutics ... | LANGER ROBERT | Director | Grant | A | 0.00 | 1,250 | 0 | 48,500 | 47.3 K to 48.5 K (+2.65 %) |
Page: 1